ClinicalTrials.govpublic full text
Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
plasma cell myeloma, plasmacytosis, recurrent plasma cell myeloma, smoldering plasma cell myeloma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 968919
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.